Literature DB >> 6800289

Familial hyperthyroxinemia due to abnormal thyroid hormone binding.

J D Silverberg, B N Premachandra.   

Abstract

A patient had an elevated serum total thyroxine (T4) free thyroxine (free T4), free T4 index, and T4/thyroxine-binding globulin ratio. The serum triiodothyronine (T3), as well as the thyrotrophin response to thyrotrophin-releasing hormone was normal and consistent with the clinical euthyroid status. The basis for the elevated serum total T4, free T4 index, and T4/thyroxine binding globulin is the abnormally enhanced binding of thyroid hormone by albumin, or by an anomalous protein migrating with a mobility similar to albumin as determined in paper electrophoretic systems. The abnormal T4 protein binding was also seen in several members of the patient's family indicating that the condition was familial. A new type of serum T4 protein binding abnormality that results in hyperthyroxinemia may falsely indicate thyrotoxicosis in clinically euthyroid subjects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800289     DOI: 10.7326/0003-4819-96-2-183

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin.

Authors:  P P Yeo; Y Yabu; J R Etzkorn; R Rajatanavin; L E Braverman; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

2.  Homozygous Mutation in Human Serum Albumin and Its Implication on Thyroid Tests.

Authors:  Mizuho S Mimoto; Anara Karaca; Neal Scherberg; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Thyroid       Date:  2018-05-24       Impact factor: 6.568

3.  Familial dysalbuminemic hyperthyroxinemia (FDH): inadequacy of the "analog" methods for assaying free-T4 levels.

Authors:  P De Nayer; P Malvaux; C Beckers
Journal:  Eur J Nucl Med       Date:  1984

Review 4.  Familial dysalbuminaemic hyperthyroxinaemia: a review.

Authors:  I W Jensen; J Faber
Journal:  J R Soc Med       Date:  1988-01       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.